Cargando…

Change in FGF23 concentration over time and its association with all-cause mortality in patients treated with haemodialysis or haemodiafiltration

BACKGROUND: Previous studies in patients on haemodialysis (HD) have shown an association of fibroblast growth factor 23 (FGF23) with all-cause mortality. As of yet, the result of FGF23 lowering on mortality is unknown in this population. METHODS: FGF23 was measured in a subset of 404 patients from t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bouma-de Krijger, Annet, de Roij van Zuijdewijn, Camiel L M, Nubé, Menso J, Grooteman, Muriel P C, Vervloet, Marc G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986440/ https://www.ncbi.nlm.nih.gov/pubmed/33777372 http://dx.doi.org/10.1093/ckj/sfaa028

Ejemplares similares

The effect of natriuretic C-type peptide and its change over time on mortality in patients on haemodialysis or haemodiafiltration
por: de Roij van Zuijdewijn, Camiel L M, et al.
Publicado: (2019)

High convection volume in online post-dilution haemodiafiltration: relevance, safety and costs
por: Mostovaya, Ira M., et al.
Publicado: (2015)

Optimization of the convection volume in online post-dilution haemodiafiltration: practical and technical issues
por: Chapdelaine, Isabelle, et al.
Publicado: (2015)

Clinical evidence on haemodiafiltration
por: Blankestijn, Peter J, et al.
Publicado: (2018)

Effect of various dialysis modalities on intradialytic hemodynamics, tissue injury and patient discomfort in chronic dialysis patients: design of a randomized cross-over study (HOLLANT)
por: Rootjes, Paul A., et al.
Publicado: (2021)

High-Volume Hemodiafiltration and Cool Hemodialysis Have a Beneficial Effect on Intradialytic Hemodynamics: A Randomized Cross-Over Trial of Four Intermittent Dialysis Strategies
por: Rootjes, Paul A., et al.
Publicado: (2022)

Aspects of platelet disturbances in haemodialysis patients
por: Schoorl, Marianne, et al.
Publicado: (2013)

Fibroblast growth factor 23: are we ready to use it in clinical practice?
por: Bouma-de Krijger, Annet, et al.
Publicado: (2020)

Serum Magnesium and Sudden Death in European Hemodialysis Patients
por: de Roij van Zuijdewijn, Camiel L. M., et al.
Publicado: (2015)

The probability of receiving a kidney transplantation in end-stage kidney disease patients who are treated with haemodiafiltration or haemodialysis: a pooled individual participant data from four randomised controlled trials
por: Vernooij, Robin W. M., et al.
Publicado: (2021)

Achieving high convection volumes in postdilution online hemodiafiltration: a prospective multicenter study
por: de Roij van Zuijdewijn, Camiel L M, et al.
Publicado: (2017)

Long-term clinical parameters after switching to nocturnal haemodialysis: a Dutch propensity-score-matched cohort study comparing patients on nocturnal haemodialysis with patients on three-times-a-week haemodialysis/haemodiafiltration
por: Jansz, Thijs Thomas, et al.
Publicado: (2018)

Impact of fractional phosphate excretion on the relation of FGF23 with outcome in CKD patients
por: Bech, Anneke P., et al.
Publicado: (2015)

Long-Term Peridialytic Blood Pressure Patterns in Patients Treated by Hemodialysis and Hemodiafiltration
por: Rootjes, Paul A., et al.
Publicado: (2020)

Long-term peridialytic blood pressure changes are related to mortality
por: de Roij van Zuijdewijn, Camiel L M, et al.
Publicado: (2022)

Online-haemodiafiltration vs. conventional haemodialysis: a cross-over study
por: Jean, Guillaume, et al.
Publicado: (2015)

Benefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis: the comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol
por: Blankestijn, Peter J, et al.
Publicado: (2020)

Haemodiafiltration elicits less platelet activation compared to haemodialysis
por: Becs, Gergely, et al.
Publicado: (2016)

Retention of beneficial molecules and coagulation factors during haemodialysis and haemodiafiltration
por: Voigt, Manuel, et al.
Publicado: (2019)

Efficacy of enoxaparin in preventing coagulation during high-flux haemodialysis, expanded haemodialysis and haemodiafiltration
por: Santos, Alba, et al.
Publicado: (2020)

Will another trial CONVINCE nephrologists to adopt high-dose haemodiafiltration over conventional haemodialysis?
por: Mayne, Kaitlin J, et al.
Publicado: (2023)

Coagulation activation, depletion of platelet granules and endothelial integrity in case of uraemia and haemodialysis treatment
por: Schoorl, Marianne, et al.
Publicado: (2013)

Measuring intradialyser transmembrane and hydrostatic pressures: pitfalls and relevance in haemodialysis and haemodiafiltration
por: Ficheux, Alain, et al.
Publicado: (2019)

High dose haemodialysis and haemodiafiltration parameters and the relationship with advanced vascular calcification
por: Park, Sung Keun, et al.
Publicado: (2020)

Haemodiafiltration and haemodialysis should be reported separately by kidney replacement therapy registries
por: Steinwandel, Ulrich, et al.
Publicado: (2022)

Short-term effects of sevelamer-carbonate on fibroblast growth factor 23 and pulse wave velocity in patients with normophosphataemic chronic kidney disease Stage 3
por: Bouma-de Krijger, Annet, et al.
Publicado: (2019)

Influence of exogenous growth hormone administration on circulating concentrations of α-klotho in healthy and chronic kidney disease subjects: a prospective, single-center open case-control pilot study
por: Adema, Aaltje Y., et al.
Publicado: (2018)

Electron microscopic observation in case of platelet activation in a chronic haemodialysis subject
por: Schoorl, Marianne, et al.
Publicado: (2011)

Shedding Light on the Complex Regulation of FGF23
por: Vervloet, Marc G.
Publicado: (2022)

Serum Levels and Removal by Haemodialysis and Haemodiafiltration of Tryptophan-Derived Uremic Toxins in ESKD Patients
por: Paats, Joosep, et al.
Publicado: (2020)

Bisphosphonate nephropathy: A case series and review of the literature
por: de Roij van Zuijdewijn, Camiel, et al.
Publicado: (2021)

Effect of increased convective clearance by on-line hemodiafiltration on all cause and cardiovascular mortality in chronic hemodialysis patients – the Dutch CONvective TRAnsport STudy (CONTRAST): rationale and design of a randomised controlled trial [ISRCTN38365125]
por: Penne, E Lars, et al.
Publicado: (2005)

Effect of haemodiafiltration vs conventional haemodialysis on growth and cardiovascular outcomes in children – the HDF, heart and height (3H) study
por: Shroff, Rukshana, et al.
Publicado: (2018)

Personalizing treatment in end-stage kidney disease: deciding between haemodiafiltration and haemodialysis based on individualized treatment effect prediction
por: van Kruijsdijk, Rob C M, et al.
Publicado: (2022)

Premature Aging of the Microcirculation in Patients with Advanced Chronic Kidney Disease
por: Thang, Oanh H.D., et al.
Publicado: (2012)

Connective Tissue Growth Factor Is Related to All-cause Mortality in Hemodialysis Patients and Is Lowered by On-line Hemodiafiltration: Results from the Convective Transport Study
por: den Hoedt, Claire H., et al.
Publicado: (2019)

Using the cytokinesis-block micronucleus cytome assay to evaluate chromosomal DNA damage in chronic renal patients undergoing bicarbonate haemodialysis and haemodiafiltration
por: GUIDO, M., et al.
Publicado: (2016)

FGF23, alpha-Klotho and vitamin D mediated calcium-phosphate metabolism in haemodialysis patients
por: Pasaoglu, Ozge Tugce, et al.
Publicado: (2021)

Effects of intravenous iron on fibroblast growth factor 23 (FGF23) in haemodialysis patients: a randomized controlled trial
por: Roberts, Matthew A., et al.
Publicado: (2016)

Haemodiafiltration—optimal efficiency and safety
por: Ledebo, Ingrid, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_op5uev12c02iev7c7e7e4grqhg